Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund 13F holdings
Mairs & Power Growth Fund's Portfolio
- Portfolio value:
- $4.62B≈
- # of securities:
- 55
- Reported for:
- 31 Dec 2019 (Q4)
- Latest filing date:
- 13 Feb 2020
What was Mairs & Power Growth Fund's 2019 Q4 portfolio?
Mairs & Power Growth Fund has disclosed a total of 55 security holdings in their (2019 Q4) SEC filing(s) with portfolio value of $4,619,577,718.
Mairs & Power Growth Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Mairs & Power Growth Fund's original SEC reports (2019 Q4) are the official SEC institutional disclosure documents covering all reported equity positions.
55 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Alphabet Inc, CL-C
|
5.67%
|
$66.85
|
+416.82%($345.50)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
U.S. Bancorp
|
5.04%
|
$59.29
|
+7.62%($63.80)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
-0.88% (-35K)
|
||||
|
|
Medtronic PLC
|
4.24%
|
$113.45
|
-26.71%($83.15)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
3M Company
|
4.01%
|
$176.42
|
-8.46%($161.50)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
Ecolab Inc
|
3.91%
|
$192.99
|
+42.29%($274.61)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
Microsoft Corp
|
3.84%
|
$157.70
|
+149.06%($392.76)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
Johnson & Johnson
|
3.69%
|
$145.87
|
+73.69%($253.37)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
+0.86% (+10K)
|
||||
|
|
Walt Disney Company
|
3.38%
|
$144.63
|
-32.48%($97.65)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
UnitedHealth Group Incorporated
|
3.35%
|
$293.98
|
+47.16%($432.61)
|
2019 Q3
|
≈ 0.50 years
|
Common Stock
|
|
||||
|
|
Roche Holding Ltd ADR
|
3.26%
|
$40.66
|
|
2019 Q3
|
≈ 0.50 years
|
Depositary Receipt
|
|
||||
Completely sold out
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.